MICKA, Miroslav and Vítězslav BRYJA. Can We Pharmacologically Target Dishevelled: The Key Signal Transducer in the Wnt Pathways? In Schulte G., Kozielewicz P. Pharmacology of the WNT Signaling System. Cham (Švýcarsko): Springer, 2021, p. 117-135. Handbook of Experimental Pharmacology, vol. 269. ISBN 978-3-030-85498-0. Available from: https://dx.doi.org/10.1007/164_2021_527.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Can We Pharmacologically Target Dishevelled: The Key Signal Transducer in the Wnt Pathways?
Authors MICKA, Miroslav (203 Czech Republic, belonging to the institution) and Vítězslav BRYJA (203 Czech Republic, belonging to the institution).
Edition Cham (Švýcarsko), Pharmacology of the WNT Signaling System, p. 117-135, 19 pp. Handbook of Experimental Pharmacology, vol. 269, 2021.
Publisher Springer
Other information
Original language English
Type of outcome Chapter(s) of a specialized book
Field of Study 30104 Pharmacology and pharmacy
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
Publication form printed version "print"
WWW URL
RIV identification code RIV/00216224:14310/21:00123816
Organization unit Faculty of Science
ISBN 978-3-030-85498-0
Doi http://dx.doi.org/10.1007/164_2021_527
Keywords in English Casein kinase 1; Dishevelled; DIX oligomerization; PDZ inhibitors; Wnt signalling-related diseases
Tags rivok, topvydavatel
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 23/3/2022 09:16.
Abstract
Dishevelled (DVL) is the central signal transducer in both Wnt/β-catenin-dependent and independent signalling pathways. DVL is required to connect receptor complexes and downstream effectors. Since proximal Wnt pathway components and DVL itself are upregulated in many types of cancer, DVL represents an attractive therapeutic target in the Wnt-addicted cancers and other disorders caused by aberrant Wnt signalling. Here, we discuss progress in several approaches for the modulation of DVL function and hence inhibition of the Wnt signalling. Namely, we sum up the potential of modulation of enzymes that control post-translational modification of DVL - such as inhibition of DVL kinases or promotion of DVL ubiquitination and degradation. In addition, we discuss research directions that can take advantage of direct interaction with the protein domains essential for DVL function: the inhibition of DIX- and DEP-domain mediated polymerization and interaction of DVL PDZ domain with its ligands.
Links
EF16_025/0007381, research and development projectName: Preklinická progrese nových organických sloučenin s cílenou biologickou aktivitou
PrintDisplayed: 29/7/2024 18:33